During the past decade, Markusovszky Egyetemi Oktatókórház conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 17 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 13 clinical trials were completed. i.e. 118.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Markusovszky Egyetemi Oktatókórház" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 4 trials sponsored, "Henogen" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Markusovszky Egyetemi Oktatókórház" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Markusovszky Egyetemi Oktatókórház" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Hepatitis B" (3 trials), "Cardiovascular Disease" (2 trials), "Crohn Disease" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Markusovszky Egyetemi Oktatókórház" in a lesser frequency.

Most popular intervention types in "Markusovszky Egyetemi Oktatókórház" are "Drug" (40 trials), "Biological" (10 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Carboplatin" (5 trials), "Bevacizumab" (4 trials), "Paclitaxel" (4 trials) and "Guselkumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Markusovszky Egyetemi Oktatókórház" are 45 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Markusovszky Egyetemi Oktatókórház". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Markusovszky Egyetemi Oktatókórház, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Markusovszky Egyetemi Oktatókórház, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Markusovszky Egyetemi Oktatókórház has several departments that took part in Clinical trials: "Markusovszky Egyetemi Oktatokorhaz, Onkoradiologiai Osztaly" - 2 trials